Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims
- PMID: 21666853
- PMCID: PMC3109659
- DOI: 10.1007/s12975-011-0074-4
Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims
References
-
- NINDS. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333(24):1581–7. - PubMed
-
- Petty GW, Brown RD, Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31 (5):1062–8. - PubMed
-
- Petty GW, Brown RD, Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30(12):2513–6. - PubMed
-
- Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40(12):e647–56. - PubMed
-
- Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources